REIT - Diversified
Compare Stocks
5 / 10Stock Comparison
AAT vs NXRT vs IIPR vs CPT vs EQR
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Residential
REIT - Industrial
REIT - Residential
REIT - Residential
AAT vs NXRT vs IIPR vs CPT vs EQR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Diversified | REIT - Residential | REIT - Industrial | REIT - Residential | REIT - Residential |
| Market Cap | $1.29B | $760M | $1.64B | $10.87B | $24.56B |
| Revenue (TTM) | $436M | $252M | $263M | $1.18B | $3.12B |
| Net Income (TTM) | $71M | $-32M | $120M | $388M | $954M |
| Gross Margin | 61.1% | 91.1% | 60.3% | 61.3% | 46.3% |
| Operating Margin | 33.5% | 11.5% | 46.7% | 18.1% | 28.5% |
| Forward P/E | 45.7x | — | 13.5x | 67.0x | 47.7x |
| Total Debt | $1.71B | $1.56B | $394M | $3.90B | $8.78B |
| Cash & Equiv. | $129M | $14M | $48M | $25M | $56M |
AAT vs NXRT vs IIPR vs CPT vs EQR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| American Assets Tru… (AAT) | 100 | 80.4 | -19.6% |
| NexPoint Residentia… (NXRT) | 100 | 93.7 | -6.3% |
| Innovative Industri… (IIPR) | 100 | 70.1 | -29.9% |
| Camden Property Tru… (CPT) | 100 | 113.3 | +13.3% |
| Equity Residential (EQR) | 100 | 108.2 | +8.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AAT vs NXRT vs IIPR vs CPT vs EQR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AAT lags the leaders in this set but could rank higher in a more targeted comparison.
NXRT is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 12 yrs, beta 0.61, yield 7.0%
- Beta 0.61, yield 7.0%, current ratio 0.48x
IIPR carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 439.9% 10Y total return vs CPT's 66.4%
- Lower P/E (13.5x vs 47.7x), PEG 3.60 vs 9.36
- 45.6% margin vs NXRT's -12.7%
- 13.3% yield, 9-year raise streak, vs NXRT's 7.0%
CPT is the #2 pick in this set and the best alternative if sleep-well-at-night and valuation efficiency is your priority.
- Lower volatility, beta 0.32, Low D/E 87.9%, current ratio 0.10x
- PEG 2.87 vs EQR's 9.36
- Beta 0.32 vs IIPR's 0.91
EQR ranks third and is worth considering specifically for growth exposure.
- Rev growth 4.1%, EPS growth 7.0%, 3Y rev CAGR 4.3%
- 4.1% FFO/revenue growth vs IIPR's -13.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.1% FFO/revenue growth vs IIPR's -13.8% | |
| Value | Lower P/E (13.5x vs 47.7x), PEG 3.60 vs 9.36 | |
| Quality / Margins | 45.6% margin vs NXRT's -12.7% | |
| Stability / Safety | Beta 0.32 vs IIPR's 0.91 | |
| Dividends | 13.3% yield, 9-year raise streak, vs NXRT's 7.0% | |
| Momentum (1Y) | +16.6% vs NXRT's -13.8% | |
| Efficiency (ROA) | 5.1% ROA vs NXRT's -1.7%, ROIC 4.3% vs 1.1% |
AAT vs NXRT vs IIPR vs CPT vs EQR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
AAT vs NXRT vs IIPR vs CPT vs EQR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
IIPR leads in 3 of 6 categories
AAT leads 0 • NXRT leads 0 • CPT leads 0 • EQR leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — IIPR and CPT each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EQR is the larger business by revenue, generating $3.1B annually — 12.4x NXRT's $252M. IIPR is the more profitable business, keeping 45.6% of every revenue dollar as net income compared to NXRT's -12.7%. On growth, EQR holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $436M | $252M | $263M | $1.2B | $3.1B |
| EBITDAEarnings before interest/tax | $273M | $125M | $197M | $867M | $1.9B |
| Net IncomeAfter-tax profit | $71M | -$32M | $120M | $388M | $954M |
| Free Cash FlowCash after capex | $95M | $79M | $144M | $714M | $1.3B |
| Gross MarginGross profit ÷ Revenue | +61.1% | +91.1% | +60.3% | +61.3% | +46.3% |
| Operating MarginEBIT ÷ Revenue | +33.5% | +11.5% | +46.7% | +18.1% | +28.5% |
| Net MarginNet income ÷ Revenue | +16.4% | -12.7% | +45.6% | +32.8% | +30.6% |
| FCF MarginFCF ÷ Revenue | +21.7% | +31.2% | +54.7% | +60.4% | +42.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.0% | +0.5% | -3.8% | -100.0% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -65.4% | 0.0% | -1.0% | +11.1% | -64.2% |
Valuation Metrics
IIPR leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 14.6x trailing earnings, IIPR trades at a 50% valuation discount to CPT's 29.3x P/E. Adjusting for growth (PEG ratio), CPT offers better value at 1.26x vs EQR's 4.42x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.3B | $760M | $1.6B | $10.9B | $24.6B |
| Enterprise ValueMkt cap + debt − cash | $2.9B | $2.3B | $2.0B | $14.7B | $33.3B |
| Trailing P/EPrice ÷ TTM EPS | 22.87x | -23.77x | 14.58x | 29.31x | 22.52x |
| Forward P/EPrice ÷ next-FY EPS est. | 45.74x | — | 13.49x | 66.98x | 47.69x |
| PEG RatioP/E ÷ EPS growth rate | 1.54x | — | 3.89x | 1.26x | 4.42x |
| EV / EBITDAEnterprise value multiple | 10.50x | 18.63x | 10.01x | 16.38x | 15.55x |
| Price / SalesMarket cap ÷ Revenue | 2.96x | 3.02x | 6.16x | 6.91x | 7.92x |
| Price / BookPrice ÷ Book value/share | 1.48x | 2.53x | 0.88x | 2.54x | 2.23x |
| Price / FCFMarket cap ÷ FCF | 13.62x | 9.09x | 9.37x | 28.14x | 19.04x |
Profitability & Efficiency
IIPR leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
CPT delivers a 8.7% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-10 for NXRT. IIPR carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), CPT scores 7/9 vs IIPR's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.4% | -10.1% | +6.4% | +8.7% | +8.4% |
| ROA (TTM)Return on assets | +2.4% | -1.7% | +5.1% | +4.3% | +4.6% |
| ROICReturn on invested capital | +4.1% | +1.1% | +4.3% | +2.6% | +4.2% |
| ROCEReturn on capital employed | +4.9% | +1.5% | +5.8% | +3.4% | +5.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 4 | 7 | 6 |
| Debt / EquityFinancial leverage | 1.56x | 5.18x | 0.21x | 0.88x | 0.77x |
| Net DebtTotal debt minus cash | $1.6B | $1.5B | $346M | $3.9B | $8.7B |
| Cash & Equiv.Liquid assets | $129M | $14M | $48M | $25M | $56M |
| Total DebtShort + long-term debt | $1.7B | $1.6B | $394M | $3.9B | $8.8B |
| Interest CoverageEBIT ÷ Interest expense | 1.92x | 0.47x | 6.67x | 3.89x | 5.58x |
Total Returns (Dividends Reinvested)
IIPR leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EQR five years ago would be worth $10,546 today (with dividends reinvested), compared to $5,308 for IIPR. Over the past 12 months, IIPR leads with a +16.6% total return vs NXRT's -13.8%. The 3-year compound annual growth rate (CAGR) favors AAT at 9.9% vs NXRT's -5.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +13.8% | +3.1% | +19.6% | -4.8% | +7.9% |
| 1-Year ReturnPast 12 months | +16.2% | -13.8% | +16.6% | -8.1% | -2.0% |
| 3-Year ReturnCumulative with dividends | +32.8% | -15.2% | +15.1% | +4.8% | +17.0% |
| 5-Year ReturnCumulative with dividends | -21.1% | -23.0% | -46.9% | +0.1% | +5.5% |
| 10-Year ReturnCumulative with dividends | -22.1% | +212.1% | +439.9% | +66.4% | +28.9% |
| CAGR (3Y)Annualised 3-year return | +9.9% | -5.3% | +4.8% | +1.6% | +5.4% |
Risk & Volatility
Evenly matched — AAT and CPT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CPT is the less volatile stock with a 0.32 beta — it tends to amplify market swings less than IIPR's 0.91 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AAT currently trades 97.4% from its 52-week high vs NXRT's 78.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.64x | 0.61x | 0.91x | 0.32x | 0.37x |
| 52-Week HighHighest price in past year | $21.61 | $38.30 | $61.40 | $119.89 | $71.80 |
| 52-Week LowLowest price in past year | $17.72 | $23.79 | $44.58 | $96.53 | $57.58 |
| % of 52W HighCurrent price vs 52-week peak | +97.4% | +78.2% | +93.3% | +86.6% | +91.3% |
| RSI (14)Momentum oscillator 0–100 | 62.6 | 70.4 | 56.4 | 54.0 | 67.3 |
| Avg Volume (50D)Average daily shares traded | 342K | 213K | 297K | 1.0M | 2.4M |
Analyst Outlook
Evenly matched — NXRT and IIPR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AAT as "Buy", NXRT as "Hold", IIPR as "Hold", CPT as "Hold", EQR as "Hold". Consensus price targets imply 47.8% upside for IIPR (target: $85) vs -12.1% for AAT (target: $19). For income investors, IIPR offers the higher dividend yield at 13.30% vs CPT's 4.10%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $18.50 | $27.00 | $84.67 | $111.58 | $70.61 |
| # AnalystsCovering analysts | 11 | 10 | 11 | 41 | 46 |
| Dividend YieldAnnual dividend ÷ price | +6.5% | +7.0% | +13.3% | +4.1% | +4.1% |
| Dividend StreakConsecutive years of raises | 5 | 12 | 9 | 4 | 8 |
| Dividend / ShareAnnual DPS | $1.37 | $2.11 | $7.62 | $4.25 | $2.69 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +1.0% | +1.2% | +2.5% | +1.1% |
IIPR leads in 3 of 6 categories — strongest in Valuation Metrics and Profitability & Efficiency. 3 categories are tied.
AAT vs NXRT vs IIPR vs CPT vs EQR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AAT or NXRT or IIPR or CPT or EQR a better buy right now?
For growth investors, Equity Residential (EQR) is the stronger pick with 4.
1% revenue growth year-over-year, versus -13. 8% for Innovative Industrial Properties, Inc. (IIPR). Innovative Industrial Properties, Inc. (IIPR) offers the better valuation at 14. 6x trailing P/E (13. 5x forward), making it the more compelling value choice. Analysts rate American Assets Trust, Inc. (AAT) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AAT or NXRT or IIPR or CPT or EQR?
On trailing P/E, Innovative Industrial Properties, Inc.
(IIPR) is the cheapest at 14. 6x versus Camden Property Trust at 29. 3x. On forward P/E, Innovative Industrial Properties, Inc. is actually cheaper at 13. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Camden Property Trust wins at 2. 87x versus Equity Residential's 9. 36x.
03Which is the better long-term investment — AAT or NXRT or IIPR or CPT or EQR?
Over the past 5 years, Equity Residential (EQR) delivered a total return of +5.
5%, compared to -46. 9% for Innovative Industrial Properties, Inc. (IIPR). Over 10 years, the gap is even starker: IIPR returned +439. 9% versus AAT's -22. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AAT or NXRT or IIPR or CPT or EQR?
By beta (market sensitivity over 5 years), Camden Property Trust (CPT) is the lower-risk stock at 0.
32β versus Innovative Industrial Properties, Inc. 's 0. 91β — meaning IIPR is approximately 186% more volatile than CPT relative to the S&P 500. On balance sheet safety, Innovative Industrial Properties, Inc. (IIPR) carries a lower debt/equity ratio of 21% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AAT or NXRT or IIPR or CPT or EQR?
By revenue growth (latest reported year), Equity Residential (EQR) is pulling ahead at 4.
1% versus -13. 8% for Innovative Industrial Properties, Inc. (IIPR). On earnings-per-share growth, the picture is similar: Camden Property Trust grew EPS 136. 0% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, EQR leads at 4. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AAT or NXRT or IIPR or CPT or EQR?
Innovative Industrial Properties, Inc.
(IIPR) is the more profitable company, earning 43. 0% net margin versus -12. 7% for NexPoint Residential Trust, Inc. — meaning it keeps 43. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IIPR leads at 46. 7% versus 11. 1% for NXRT. At the gross margin level — before operating expenses — IIPR leads at 88. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AAT or NXRT or IIPR or CPT or EQR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Camden Property Trust (CPT) is the more undervalued stock at a PEG of 2. 87x versus Equity Residential's 9. 36x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Innovative Industrial Properties, Inc. (IIPR) trades at 13. 5x forward P/E versus 67. 0x for Camden Property Trust — 53. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IIPR: 47. 8% to $84. 67.
08Which pays a better dividend — AAT or NXRT or IIPR or CPT or EQR?
All stocks in this comparison pay dividends.
Innovative Industrial Properties, Inc. (IIPR) offers the highest yield at 13. 3%, versus 4. 1% for Camden Property Trust (CPT).
09Is AAT or NXRT or IIPR or CPT or EQR better for a retirement portfolio?
For long-horizon retirement investors, Camden Property Trust (CPT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
32), 4. 1% yield). Both have compounded well over 10 years (CPT: +66. 4%, AAT: -22. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AAT and NXRT and IIPR and CPT and EQR?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AAT is a small-cap income-oriented stock; NXRT is a small-cap income-oriented stock; IIPR is a small-cap deep-value stock; CPT is a mid-cap income-oriented stock; EQR is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.